Immunotherapy for
oncological diseases
We stimulate your own immunity to precisely destroy mutated cells — effective even at advanced stages.
Adaptation of cancer cells
Two factors limiting the effectiveness of standard chemotherapy and radiotherapy.
Immune masking
Cancer cells can secrete specific proteins and substances that suppress T-lymphocyte activity. As a result, the immune system stops recognizing mutated tissues as a threat, perceiving metastases as its own healthy cells. This forms the phenomenon of a 'cold' tumor, invisible to natural defense.
Cellular resistance
Classic cytoreductive therapy (chemotherapy and radiation) destroys cancer but simultaneously depletes the body's own immune resources. Surviving mutated cells can eventually develop resistance to toxins. They adapt to medications, causing the effectiveness of standard protocols to gradually decline.
We train immunity outside the body,
where the tumor is completely powerless
Isolation and no intoxication
Isolation and no intoxication
We draw up to 90 ml of your blood. Since the reprogramming of immune cells happens outside the body, we do not introduce systemic toxins into your system. The therapy causes absolutely no damage to healthy tissues, entirely ruling out side effects such as hair loss, liver damage, and severe nausea.
Efficacy at stages III-IV
Efficacy at stages III-IV
During 18 hours of laboratory incubation, your cells regain the ability to recognize cancer as a threat. They strip away the tumor's camouflage and receive a clear target for attack. This makes it possible to halt disease progression even when the options for traditional chemotherapy and radiation are completely exhausted.
Targeted strike
Targeted strike
The trained immunocompetent cells are returned to the patient and begin to selectively attack tumor tissues. The method combines perfectly with surgery: the powerful immune response acts like a 'smart radar,' independently locating and destroying micrometastases that might have remained after the operation.
Consolidation and long-term memory
Consolidation and long-term memory
Any chemotherapy drug stops working as soon as it is cleared from the body. Trained immunity, by contrast, becomes a natural biological shield: specific memory cells continue to circulate in your blood, protecting the body from relapses for years.
Target therapy directions
Melanoma
Activation of your own cells to destroy metastases. Proven efficacy even at advanced stages.
Kidney cancer
Specific immune response against renal cell carcinoma without severe toxic burden.
Colorectal cancer
Personalized therapy for colon and rectal tumors, improving prognosis and quality of life.
Lung cancer
Comprehensive impact on the tumor while preserving healthy tissues across various forms of lung cancer.
CNS tumors (gliomas)
An innovative approach to treating gliomas and astrocytomas using primed immunocompetent cells.
Prostate cancer
Targeted inhibition of the tumor process and disease control to achieve long-term remission.
Breast cancer
Forming long-term antitumor defense, reducing the risks of relapses and metastasis.
Ovarian cancer
Adoptive therapy opening new treatment possibilities even when chemotherapy standards are exhausted.
Pancreatic cancer
Integrative techniques to enhance the immune response in aggressive forms of the disease.
Stomach cancer
Safe restoration of antitumor immunity for a targeted fight against cancer cells.
Thyroid cancer
Activation of antitumor immunity as an addition to surgical and radioiodine treatment.
Oncology Treatment Protocol
A standardized cycle from the initial medical board to the formation of a long-term immune response.
Discuss your situation
Leave your contact details. Our medical coordinator will contact you shortly to answer any questions.